Hypertrophic cardiomyopathy: a practical approach to guideline directed management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34600606.
- Also identified by DOI 10.1016/S0140-6736(21)01205-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hypertrophic cardiomyopathy, one of the most common genetic cardiovascular conditions, will be encountered by nearly every health-care provider regardless of specialty. In 2020, new hypertrophic cardiomyopathy management guidelines were published, updating and evolving preceding versions. This Seminar provides a concise review and practical guide to the updated recommendations for patients with hypertrophic cardiomyopathy.
Medical subject headings
- Cardiac Myosins
- Cardiomyopathy, Hypertrophic
- Carrier Proteins
- Genetic Predisposition to Disease
- Guidelines as Topic
- Myosin Heavy Chains